title: Dapsone-induced artifactual a1c reduction in islet transplant recipients.
authors.forename: Tatiana
authors.initials: T
authors.lastname: Froud
authors.forename: Raquel N
authors.initials: RN
authors.lastname: Faradji
authors.forename: Lisa
authors.initials: L
authors.lastname: Gorn
authors.forename: Kathy
authors.initials: K
authors.lastname: Monroy
authors.forename: Charlotte
authors.initials: C
authors.lastname: Paz
authors.forename: David A
authors.initials: DA
authors.lastname: Baidal
authors.forename: Gaston
authors.initials: G
authors.lastname: Ponte
authors.forename: Pablo
authors.initials: P
authors.lastname: Cure
authors.forename: Raffaella
authors.initials: R
authors.lastname: Poggioli
authors.forename: Antonello
authors.initials: A
authors.lastname: Pileggi
authors.forename: Camillo
authors.initials: C
authors.lastname: Ricordi
authors.forename: Rodolfo
authors.initials: R
authors.lastname: Alejandro
mesh_terms: D003622:Dapsone / Q000009:adverse effects*; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery; D005189:False Positive Reactions; D006442:Glycated Hemoglobin / Q000378:metabolism*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016381:Islets of Langerhans Transplantation / Q000379:methods*; D015203:Reproducibility of Results; D016896:Treatment Outcome
chemical_list: D003622:Dapsone; D006442:Glycated Hemoglobin; D007166:Immunosuppressive Agents